122 research outputs found

    Has IL2 a role in the management of minimal residual disease for acute leukemia?

    No full text
    Based on pre-clinical findings and on more recent preliminary in vivo data it has been suggested that immunotherapy with Interleukin 2 (IL2) may be employed in the treatment of acute leukemia patients. Here we shall discuss the biological and clinical observations which indicate that this innovative therapeutic approach may play a role in the management of minimal residual disease

    Leberzellpermeabilit�t unter dem Einfluss von Prednisolon

    No full text
    • …
    corecore